Research presented at DDW 2016 provides the strongest evidence to date that surveillance of Barrett’s esophagus patients with short segments and irregular Z lines is not needed.
Join the multidisciplinary team as they review innovation and updates in key topics in Hepatobiliary and Pancreatic Diseases.
A sleep positioning device that significantly decreases nocturnal gastroesophageal reflux disease symptoms is proving successful in hard-to-treat laryngopharyngeal reflux patients.
The American College of Gastroenterology has named the Edgar Achkar Visiting Professorship Program to honor long-time Cleveland Clinic GI specialist Edgar Achkar, MD.
A Cleveland Clinic study found a two-piece positional therapy device significantly reduces nocturnal gastroesophageal reflux disease symptoms and improves overall sleep quality in pregnancy women.
Endoscopic submucosal dissection, a technique pioneered in Japan, is offering a less invasive alternative to surgery for patients with early gastrointestinal tumors.
Isoprene in exhaled breath is highly accurate in detecting advanced liver fibrosis and could avoid the need for biopsy in up to 75 percent of patients.
A sleep positioning device not only significantly decreases nocturnal gastroesophageal reflux disease, but it also dramatically improves quality of life, according to Cleveland Clinic research.
Cleveland Clinic researchers led by Bo Shen, MD, have discovered a connection between the intestines and the heart that could lead to new protocols in the treatment of coronary artery disease.
Cleveland Clinic staff will present nearly 50 different topics at Digestive Disease Week this year. Find out about the sessions you won’t want to miss.